Daniel Virnich - 07 Dec 2022 Form 4 Insider Report for Oncology Institute, Inc. (TOI)

Role: President
Signature: By: Mark Hueppelsheuser For: Daniel Virnich
Issuer symbol: TOI
Transactions as of: 07 Dec 2022
Net transactions value: +$301,000
Form type: 4
Filing time: 08 Dec 2022, 18:02:26 UTC
Previous filing: 21 Nov 2022
Next filing: 21 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TOI	Common Stock	Options Exercise	$150,500	+175,000	+64%	$0.8600	448,585	07 Dec 2022	Direct
transaction	TOI	Common Stock	Options Exercise	$150,500	+175,000	+39%	$0.8600	623,585	07 Dec 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TOI	Non-Qualified Stock Option (right to buy)	Options Exercise	$0	-175,000	-17%	$0.000000	829,609	07 Dec 2022	Common Stock	175,000	$0.8600	Direct	F1
transaction	TOI	Non-Qualified Stock Option (right to buy)	Options Exercise	$0	-175,000	-21%	$0.000000	654,609	07 Dec 2022	Common Stock	175,000	$0.8600	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These options vest monthly for 36 months following November 12, 2021, the date of the closing of the Business Combination.
F2	These options vest as to 1/4th of the total number of shares subject to the option on the first anniversary of March 1, 2020 (the "Original Grant Date"), and as to 1/36th of the total number of shares monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Original Grant Date, subject to continued employment through the vest date.

Content

These options vest monthly for 36 months following November 12, 2021, the date of the closing of the Business Combination.

These options vest as to 1/4th of the total number of shares subject to the option on the first anniversary of March 1, 2020 (the "Original Grant Date"), and as to 1/36th of the total number of shares monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Original Grant Date, subject to continued employment through the vest date.